General Information of the Compound
Compound ID
CP0578668
Compound Name
4-(5-chloropyridin-2-yl)-N-(1-methylindazol-6-yl)piperazine-1-carboxamide
    Show/Hide
Structure
Formula
C18H19ClN6O
Molecular Weight
370.844
Canonical SMILES
Cn1ncc2ccc(NC(=O)N3CCN(CC3)c3ccc(Cl)cn3)cc12
    Show/Hide
InChI
InChI=1S/C18H19ClN6O/c1-23-16-10-15(4-2-13(16)11-21-23)22-18(26)25-8-6-24(7-9-25)17-5-3-14(19)12-20-17/h2-5,10-12H,6-9H2,1H3,(H,22,26)
    Show/Hide
InChIKey
NJNAWYLWFUAAIH-UHFFFAOYSA-N
Physicochemical Property
logP
2.9758
Rotatable Bonds
2
Heavy Atom Count
26
Polar Areas
66.29
Hydrogen Bond Donor Count
1
Hydrogen Bond Acceptor Count
5
Complexity
26

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
PubChem ID
CID: 168289798
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT02183, Transient receptor potential cation channel subfamily V member 1
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
EC50 = 3556 nM
   TI
   LI
   LO
   TS